it has been shown to increase locomotor activity, elicit zyban more for patients mild zyban more for patients behavioral response, and increase rates of responding in several schedule-controlled behavior paradigms. In primate models to assess zyban more for patients positive reinforcing effects of zyban more for patients drugs, bupropion was self-administered intravenously. In rats, bupropion produced.

Treatment with ZYBAN should be initiated while the patient zyban more for patients still smoking, since approximately 1 week of treatment is required to achieve steady-state blood levels of bupropion. Patients should set a “target zyban more for patients date” within the first 2 weeks of zyban more for patients with ZYBAN, generally zyban more for patients the second week. Treatment with ZYBAN should zyban more for patients continued zyban more for patients 7 to 12 weeks; longer treatment should be guided by the relative benefits and risks for individual patients. If a patient has not made significant progress zyban more for patients abstinence by the seventh week of therapy with zyban more for patients it is unlikely zyban more for patients he or she zyban more for patients quit during that attempt, and treatment zyban more for patients probably be discontinued. Conversely, a patient who successfully quits after zyban more for patients to 12 weeks of treatment should be considered for zyban more for patients therapy with ZYBAN. Dose tapering of ZYBAN is not required zyban more for patients discontinuing treatment. It is important that patients continue to receive zyban more for patients and support throughout treatment with ZYBAN, and for a period of time.

or amantadine. Administration of ZYBAN zyban more for patients patients receiving either levodopa or amantadine concurrently should.